Publicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (11)

2022

  1. The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival

    Cellular and Molecular Life Sciences, Vol. 79, Núm. 10

2019

  1. Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer

    Gynecologic Oncology, Vol. 153, Núm. 2, pp. 425-435

2017

  1. Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias

    Journal of Pathology, Vol. 242, Núm. 2, pp. 152-164

2015

  1. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

    International Journal of Cancer, Vol. 136, Núm. 8, pp. 1863-1873

2013

  1. Endometrial carcinoma: Molecular alterations involved in tumor development and progression

    Oncogene, Vol. 32, Núm. 4, pp. 403-413

  2. Epithelial-to-mesenchymal transition and stem cells in endometrial cancer

    Human Pathology, Vol. 44, Núm. 10, pp. 1973-1981

2012

  1. ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells

    International Journal of Cancer, Vol. 130, Núm. 7, pp. 1532-1543

  2. Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma

    Human Pathology, Vol. 43, Núm. 5, pp. 632-643

  3. The EMT signaling pathways in endometrial carcinoma

    Clinical and Translational Oncology, Vol. 14, Núm. 10, pp. 715-720

2011

  1. FGFR2 alterations in endometrial carcinoma

    Modern Pathology, Vol. 24, Núm. 11, pp. 1500-1510

2009

  1. Subtractive proteomic approach to the endometrial carcinoma invasion front

    Journal of Proteome Research, Vol. 8, Núm. 10, pp. 4676-4684